# RDF export of group: Publication
<http://ctro/data#Publication_8462> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_8462> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 8462" .
<http://ctro/data#Publication_8462> <http://ctro/data#hasTitle> "A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension : a 3 month , randomised study ." .
<http://ctro/data#Publication_8462> <http://ctro/data#hasAuthor> "O ' Donoghue" .
<http://ctro/data#Publication_8462> <http://ctro/data#hasPublicationYear> "2000" .
<http://ctro/data#Publication_8462> <http://ctro/data#hasJournal> "J Ophthalmol" .
<http://ctro/data#Publication_8462> <http://ctro/data#hasPMID> "10837379" .
<http://ctro/data#ClinicalTrial_8468> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_8469> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_8469> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 8469" .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasObjectiveDescription> "To compare the effects on intraocular pressure ( IOP ) and side effects of monotherapy with either latanoprost or dorzolamide in patients with glaucoma or ocular hypertension" .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasNumberPatientsCT> "224" .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTduration> "3 month" .
<http://ctro/data#AllocationRatio_8473> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_8474> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasConclusionComment> "Latanoprost was superior to dorzolamide in reducing the IOP , judged both from the effect on IOP at peak and trough and by the effect on diurnal IOP" .
<http://ctro/data#Arm_8477> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Glaucoma_8478> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_8478> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasPopulation> <http://ctro/data#Population_8484> .
<http://ctro/data#DiffBetweenGroups_8480> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#EvidenceQuality_8481> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension> .
# RDF export of group: Population
<http://ctro/data#Population_8484> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_8484> <http://www.w3.org/2000/01/rdf-schema#label> "Population 8484" .
<http://ctro/data#Population_8484> <http://ctro/data#hasPrecondition> "Previous glaucoma medications were washed out" .
<http://ctro/data#Ethnicity_8486> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Country_8487> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country> .
<http://ctro/data#Gender_8491> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
# RDF export of group: Arm
# RDF export of group: Intervention
# RDF export of group: Medication
# RDF export of group: Outcome
# RDF export of group: DiffBetweenGroups
# RDF export of group: EvidenceQuality